Zhang Bin, Ji Sheqing, Ma Fei, Ma Qi, Lu Xianzhi, Chen Xiaobing
Department of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.
Am J Cancer Res. 2016 Sep 1;6(9):2021-2030. eCollection 2016.
Dysregulation of microRNAs (miRNAs) are linked to tumorigenesis and tumor progression. In this study, we examined the expression of miR-489 in gastric cancer tissues and cells. Loss- and gain-of-function experiments were done to determine the roles of miR-489 in gastric cancer cell proliferation and invasion. Bioinformatic prediction, luciferase reporter assays, and Western blot analysis were employed to identify the target gene(s) of miR-489. We found that miR-489 was significantly ( < 0.05) downregulated in human gastric cancer tissues and cell lines, compared to their non-malignant counterparts. Enforced expression of miR-489 significantly suppressed gastric cancer cell proliferation and invasion, while miR-489 knockdown enhanced the aggressive behaviors of gastric cancer cells. Prospero homeobox 1 (PROX1) was identified to be a direct target of miR-489. A significant negative correlation was seen between miR-489 and PROX1 protein expression in gastric cancer tissues ( = -0.462, = 0.023). Silencing of PROX1 phenocopied the suppressive effects of miR-489 in gastric cancer cells. Rescue experiments demonstrated that overexpression of a miR-489-resistant form of PROX1 significantly prevented the reduction in cell proliferation and invasion induced by miR-489 overexpression. In vivo studies confirmed that miR-489 overexpression retarded the growth of xenograft tumors, which was accompanied by reduced PROX1 expression. Overall, these data provide evidence for the suppressive activity of miR-489 in gastric cancer, which is ascribed to targeting of PROX1. The miR-489/PROX1 axis may represent a potential therapeutic target for this disease.
微小RNA(miRNA)失调与肿瘤发生和肿瘤进展相关。在本研究中,我们检测了miR - 489在胃癌组织和细胞中的表达。进行了功能丧失和功能获得实验,以确定miR - 489在胃癌细胞增殖和侵袭中的作用。采用生物信息学预测、荧光素酶报告基因检测和蛋白质印迹分析来鉴定miR - 489的靶基因。我们发现,与非恶性对应物相比,miR - 489在人胃癌组织和细胞系中显著下调(<0.05)。miR - 489的强制表达显著抑制胃癌细胞增殖和侵袭,而miR - 489敲低则增强了胃癌细胞的侵袭性行为。Prospero同源盒1(PROX1)被鉴定为miR - 489的直接靶标。在胃癌组织中,miR - 489与PROX1蛋白表达之间存在显著负相关(=-0.462,=0.023)。PROX1沉默模拟了miR - 489对胃癌细胞的抑制作用。拯救实验表明,miR - 489抗性形式的PROX1过表达显著阻止了miR - 489过表达诱导的细胞增殖和侵袭减少。体内研究证实,miR - 489过表达抑制了异种移植肿瘤的生长,同时伴有PROX1表达降低。总体而言,这些数据为miR - 489在胃癌中的抑制活性提供了证据,这归因于其对PROX1的靶向作用。miR - 489/PROX1轴可能代表该疾病的潜在治疗靶点。